← Back to Newsletter Archive

Greetings!

Welcome to the Monthly QPS Preclinical Newsletter


Explore how antibody-drug conjugate (ADC) research and metabolite identification can inform your development decisions, and catch up on the latest scientific insights from the QPS Blog.


Custom-Built Research for Your Oncology ADC Program

Connect your antibody-drug conjugate (ADC) clinical trials and bioanalysis with QPS, a global, full-service CRO. Our teams combine oncology clinical expertise with specialized bioanalytical capabilities to help characterize drug exposure, evaluate safety, and assess treatment response.


With custom-built solutions and the agility to adapt as your program evolves, QPS helps you turn complex study requirements into clear data for timely development decisions.

QPS Study Experience Antibody Drug Conjugates

Reduce Uncertainty in Your Oligonucleotide Program

Build a clearer picture of your oligonucleotide’s metabolic fate to guide candidate selection and study planning. QPS combines custom-built methods, advanced mass spectrometry, and expert interpretation to identify, profile, and quantify metabolites, helping you address data gaps and prioritize your next development steps.

 

Read our white paper to explore how an integrated metabolite analysis strategy can support your program.

Explore the White Paper

Therapeutic Oligonucleotide Metabolite Identification, Profiling and Quantitation

Discover the Future of Science on the QPS Blog

Bayesian Statistics in Clinical Trials: Learning From the Past



Could a statistical approach developed more than 250 years ago help make modern clinical trials more efficient and less costly? Bayesian statistics offers...


Two Approaches to Interpreting Clinical Data

Clinical Data Management at QPS

Antibody-Drug Conjugates: Oncology Therapy Developments


The 2026 World Conference on Lung Cancer (WCLC), the biggest annual meeting on lung cancer research, recently wrapped up, and the…


All Eyes on ADC Lung Cancer Studies

Oncology Clinical Trials at QPS

Contact the Experts at QPS

 

Request a meeting with QPS preclinical, bioanalysis, translational medicine, and/or clinical research subject matter experts today to explore how we can help accelerate your next drug development program.

Visit our website www.qps.com 

or contact us at infopr@qps.com

to start your next study.

Linkedin  Youtube  X  Facebook

View as Webpage

www.qps.com | infopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive